Aeon Biopharma Inc (AEON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 13,046 | 37,700 | 9,913 | 427 | 389 |
| Operating Income | -13,046 | -37,700 | -9,913 | -427 | -389 |
| Other Income | -4,593 | -9,076 | -525 | 2,311 | 3,163 |
| Pre-tax Income | -17,639 | -46,776 | -10,438 | 1,884 | 2,773 |
| Income Tax | N/A | N/A | N/A | 17 | N/A |
| Net Income Continuous | -17,639 | -46,759 | -10,438 | 1,867 | 2,773 |
| Net Income | $-17,639 | $-46,759 | $-10,438 | $1,867 | $2,773 |
| EPS Basic Total Ops | -9.35 | -30.94 | -5.76 | 3.60 | 5.76 |
| EPS Basic Continuous Ops | -9.14 | -70.21 | -5.41 | 19.47 | 28.92 |
| EPS Diluted Total Ops | -9.35 | -30.94 | -5.76 | 3.60 | 5.76 |
| EPS Diluted Continuous Ops | -9.14 | -70.21 | -5.41 | 19.47 | 28.92 |
| EBITDA(a) | $-13,021 | $-37,668 | $-9,913 | $-427 | $-389 |